We have collected information about Biodelivery Endo for you. Follow the links to find out details on Biodelivery Endo.
BioDelivery Sciences (BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA ® ) technology and other drug delivery technologies to develop and commercialize new applications of proven therapies aimed at addressing important unmet medical needs.
http://ir.bdsi.com/news-releases/news-release-details/biodelivery-sciences-reacquires-license-belbucatm-endo
The BioDelivery Sciences and BUNAVAIL logos are trademarks owned by BioDelivery Sciences International, Inc. BELBUCA® is a trademark currently owned by Endo Pharmaceuticals. All other trademarks and tradenames are owned by their respective owners.
https://www.prnewswire.com/news-releases/endo-pharmaceuticals-and-biodelivery-sciences-announce-acceptance-of-nda-for-belbuca-buprenorphine-hcl-buccal-film-for-the-management-of-chronic-pain-300039475.html
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine.
https://www.wsj.com/articles/endo-biodelivery-pain-drug-meets-primary-endpoint-1404736577
BioDelivery signed a license and development deal with Endo in 2012 for exclusive rights to develop and sell the drug. Write to Michael Calia at [email protected]
https://www.zacks.com/stock/news/241903/endo-endp-inks-deal-to-return-belbuca-rights-to-biodelivery
Endo (ENDP) announced that it has entered into an agreement to return the rights for Belbuca to BioDelivery (BDSI). Endo (ENDP) Inks Deal to Return Belbuca Rights to BioDelivery - December 9, …
http://ir.bdsi.com/news-releases/news-release-details/endo-pharmaceuticals-and-biodelivery-sciences-announce-nda
Learn more at www.endo.com. About BioDelivery Sciences International - BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology and other drug delivery technologies to develop and …
https://investor.endo.com/news-releases/news-release-details/endo-pharmaceuticals-and-biodelivery-sciences-present-new-data
Sep 09, 2015 · Endo Pharmaceuticals is an operating company of Endo International plc, a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Learn more at www.endo.com or www.endopharma.com. About BioDelivery Sciences International
https://www.prnewswire.com/news-releases/biodelivery-sciences-reacquires-license-to-belbuca-from-endo-pharmaceuticals-300375132.html
The BioDelivery Sciences and BUNAVAIL logos are trademarks owned by BioDelivery Sciences International, Inc. BELBUCA® is a trademark currently owned by Endo Pharmaceuticals.
https://www.endo.com/endopharma/about-us/our-story
On December 8, 2016, Endo makes a strategic decision regarding their U.S. branded pain business and returns BELBUCA™ to BioDelivery Sciences International, Inc. (BDSI). Endo’s remaining pain products, including OPANA® ER, will be part of Endo’s portfolio of established products and will no longer require promotional support.
https://www.endo.com/about-us/history
On December 8, 2016, Endo makes a strategic decision regarding their U.S. branded pain business and returns BELBUCA™ to BioDelivery Sciences International, Inc. (BDSI). Endo’s remaining pain products, including OPANA® ER, will be part of Endo’s portfolio of established products and will no longer require promotional support.
Searching for Biodelivery Endo?
You can just click the links above. The data is collected for you.
